Gabapentin
Product Images NDC 68788-7119

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-7119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Capsules Usp 400mg (civ)

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
Not available*
FDA Label Image

Gabapentin Fig1

FDA Label Image

Gabapentin Fig2

FDA Label Image

Gabapentin Fig3

Gabapentin Fig3
This text appears to be presenting data related to the proportion of responders in controlled studies for postherpetic neuralgia (PHN) and their corresponding pain reduction scores. The percentages listed (100%, 90%, 80%, etc.) could potentially represent the proportion of patients experiencing a certain level of pain reduction. Based on the text, it seems that there is a comparison being made between different treatment options, such as GBP 3600, PBO (possibly placebo), and GEBP 1800. However, without further context or clarification, it is difficult to provide a more specific description.*
FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.